ARGANZ Pancreas focus group

A/Prof Tom Sutherland is an abdominal radiologist. He has authored over 80 peer review articles and a number of text book chapters. He has a strong interest in health advocacy and keeping things simple.

North Shore & Waitakere Hospital, NZ

Dr Jash Agraval graduated from the University of Auckland Medical School in 2007 and completed his radiology training in Auckland. He then undertook subspecialty fellowship training in Oncologic and Molecular imaging at the Memorial Sloan Kettering Cancer Centre in New York, returning to Auckland in 2016. He is currently the Clinical Director of Radiology at North Shore and Waitakere Hospitals, as well as the clinical lead for the Health NZ Transforming Diagnostic Imaging (TDI) project.

Jash has subspecialty interests in PET-CT and oncologic imaging with a particular focus in hepatobiliary, gynaecologic and prostate imaging.

An active member of the Royal Australia NZ College of Radiologists (RANZCR), Jash is the Deputy Chief Censor and Chair of the Curriculum Assessment Committee. He also sits on the Education and Training Committee, Research Committee and Maori, Aboriginal and Torres Straight Islander Executive Committee. Jash is an active member of Radiology Across Borders where he is the co-lead in the International Certificate of Radiology Fundamentals (ICRF) which provides radiology education and support to developing nations.

Princess Alexandra Hospital, QLD

Dr Kate McLean is a Diagnostic Radiologist working at Princess Alexandra Hospital in Brisbane, the statewide liver and renal transplant centre. Her interest areas are hepatopancreatobiliary and colorectal imaging actively participating in these weekly multidisciplinary meetings. Kate joined the ARGANZ executive in 2025, is the lead of the Liver focus group and has presented at multiple statewide and national conferences and workshops. She is a Senior Lecturer with University of Queensland and a member of the Cancer Alliance Queensland Partnership, the RANZCR Case Reporting Examination panel and GI cancer trials.